Identification of an "Exceptional Responder" Cell Line to MEK1 Inhibition: Clinical Implications for MEK-targeted Therapy
Gannon, H. S., Kaplan, N., Tsherniak, A., Vazquez, F., Weir, B. A., Hahn, W. C., Meyerson, M.Language:
english
Journal:
Molecular Cancer Research
DOI:
10.1158/1541-7786.mcr-15-0321
Date:
November, 2015
File:
PDF, 1.69 MB
english, 2015